You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
Monoclonal antibodies targeting novel sites of vulnerability in marburg virus glycoprotein
SBC: Integrated Biotherapeutics, Inc. Topic: NIAIDFilovirusesconsisting of two major virus families including the ebolaviruses and marburgvirusesMARV and RAVVcause periodic outbreaks of severe viral hemorrhagic fever with mortality rates as high asSince it is difficult to predict the species that would dominate future outbreaksdevelopment of broadly protective therapeutics to prevent and manage future filovirus outbreaks is of high priorityIn sha ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Custom-Fit Personal Sound Amplification Smartphone Application
SBC: ASCENDING HEARING TECHNOLOGIES, LLC Topic: NIDCDPROJECT SUMMARYPersonal sound amplification productsPSAPshave recently become available to the publicPSAPs serve a potentially important role in providing audibility of sounds for adults who have difficulty hearing in some daily living situationsbut may not be candidates for traditionalhigh amplification hearing aidsFewer thanof adults with hearing loss reporting use of hearing aidsciting high cos ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A novel asthma drug candidate targeting the GABAergic system in lung inflammation
SBC: PANTHERICS INCORPORATED Topic: NHLBIThe proposed research will advance preclinical characterization and validation of a novel drug for asthmaA growing body of research has uncovered functional gamma amino butyric acid type A receptorGABAARsignaling in non neuronal cellsOur research has demonstrated that ligands activating GABAAR subtypes located on airway smooth muscle and immune cells reduce airway hyper responsivenessAHRand inflam ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Use of a Designer Proline-rich antimicrobial peptide Chaperone protein inhibitor (DPC) for treating antibiotic resistant pneumonia
SBC: Arrevus, Inc. Topic: NIAIDProject SummaryInfectious disease is the third leading cause of death in the United Statesand hospital acquired infectionsHAIsin particular affectmillion patients annuallyThe most common type of HAI is pneumoniaoften caused by multi drug resistantMDRpathogens such as Staphylococcus aureusPseudomonas aeruginosaKlebsiella pneumoniaeEscherichia coliand Acinetobacter baumanniiRates of antibiotic resis ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
MegaTrans- human transporter machine learning models
SBC: COLLABORATIONS PHARMACEUTICALS, INC. Topic: 400Summary Being able to predict interactions with important human transporters would be of value to new drug design to avoid compounds that interact with them and cause undesirable side effectsOATP BSLCO Band OATP BSLCO Bare `uptakeandapostransporters largely restricted to the sinusoidal aspect of hepatocytesThey both transport a wide variety of structurally unrelated compoundsincluding members of s ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
IRE1beta Inhibitors: Novel Therapeutics to Manage Excess Mucus in Asthma
SBC: Irex Pharma LLC Topic: NIAIDPROJECT SUMMARY Overmillion Americans have asthmawhich places an economic burden on the U Sof $billionAirway mucus overproduction is a hallmark of asthmaand the quantity and tenacity of mucus are increased during airway exacerbationsMucolytics degrade mucusbut do not reduce its productionAlthough corticosteroids and other anti inflammatory therapies indirectly decrease mucus productionand anti cho ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Aminoglycosides with reduced ototoxicity via miRNA targeting
SBC: NUBAD, LLC Topic: NIAIDPROJECT SUMMARY Aminoglycosides are one of the cheapest and well known antibiotics in clinical use for over years but one of the major limitations in their use is their ototoxicity We are developing fast and low cost methods to develop aminoglycosides with anti ribosomal activities and reduced toxicity In this project we will identify novel aminoglycoside antibacterials that show reduced ototoxici ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Web Based Therapist Training on Complicated Grief Therapy
SBC: KOBAK, KENNETH A Topic: 104Complicated GriefCGis a prevalent and debilitating disorder associated with significant distress and impairmentIt differs from major depression in its treatment and symptomatologyCG is listed in DSMas a subtype of Trauma and Greif DisorderThe World Health Organization will include CG as a stand alone disorder in ICDand it is expected that the DSMsubcommittee will follow suitTraditional forms of th ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Correction of Splicing Defects in Cystic Fibrosis with Peptide-Oligonucleotide Conjugates and Small Molecule Enhancing Compounds
SBC: Initos Pharmaceuticals LLC Topic: NCATSABSTRACT The pathogenesis of Cystic FibrosisCFis caused by mutations in the gene for CFTRa cAMP activated chloride channel that regulates salt and water transport in epithelial tissuesespecially those in the airwaysRecent progress has resulted in small molecule therapeutic agents that partially correct defects in the CFTR protein due to certain mutationsHoweverin a substantial fraction of CF patie ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Using Interactive Digital Media to Teach Cardiopulmonary Resuscitation to High School Students
SBC: CORAM TECHNOLOGIES, INC. Topic: 400Summary Abstract Out of hospital cardiac arrest affects overpeople in the U Sannuallybut onlysurviveBystander cardiopulmonary resuscitationCPRimproves survivalbut rates of training in the U Sare lowIt is recently required by law inU Sstates that high school students learn CPRHoweverthere is great variability nationwide in howby whomand when students are taughtAdditionallycurrent methods of teachin ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health